End-to-end antibody & protein engineering
Streamline discovery, accelerate innovation, and make AI-driven decisions in real time with an all-in-one platform for biologics breakthroughs.
Unlock the next generation of biopharma breakthroughs
The landscape of R&D is evolving rapidly, advancing beyond small molecule drugs to cutting-edge therapies like monoclonal antibodies, bispecifics, ADCs, CAR-Ts, and RNA therapies. However, outdated systems that isolate data, complicate analysis, and force rigid workflows are hindering progress and limiting productivity.
Introducing the all-in-one Luma Antibody & Protein Engineering solution. Powered by industry-trusted tools like Geneious and GraphPad Prism, this groundbreaking platform is transforming biologics R&D.
- Unify researchers on a comprehensive platform designed for multimodal discovery
- Build highly adaptive and flexible workflows to meet unique scientific needs
- Reduce tech stack complexity and minimize errors in data transfer
- Enhance handoffs and optimize resource and process management
- Automate the evaluation of vast volumes of complex biologics data
- Improve the likelihood of discovering viable therapeutic candidates at early stages
- Reduce time and resources spent on less promising designs
- Customize dashboards for data visualization from all discovery steps
- View complex datasets from multiple technologies—flow cytometry, expression, sequencing, and proteomics—in one intuitive interface
- Accelerate the identification of patterns and insights with real-time data integration
- Minimize the chances of incorrect conclusions and avoid costly, misguided actions
Embrace the future of therapeutic research
Simplify your path to discovery.
See Luma in action by requesting a demo today.